마취용 기관내 튜브(ETT) 시장 보고서 : 삽관방법별, 제품 유형별, 최종사용자별, 지역별(2026-2034년)

The global anesthesia endotracheal tubes market size reached USD 200.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 297.7 Million by 2034, exhibiting a growth rate (CAGR) of 4.38% during 2026-2034.

Anesthesia endotracheal tubes (ETTs) are used for intubation and manufactured using a polyvinylchloride (PVC) tube, which is inserted into the trachea and allows direct delivery of oxygen (O 2 ) and removal of carbon dioxide (CO 2 ) from the lungs. They aid in maintaining the airway passage of the lungsand allowing mechanical ventilation. They are also utilizedfor protecting the lungs from contamination of gastric contents and nasopharyngeal matter and during intermittent positive pressure ventilation (IPPV), resuscitation, Diptheria, epiglottis, and direct suctioning of the trachea in meconium aspiration. They enable healthcare professionals to sedate the patient and performing the surgical procedure. As a result, ETTsare widely used in surgery centers, trauma centers, and intensive care units (ICUs).

ANESTHESIA ENDOTRACHEAL TUBES MARKET TRENDS:

The increasing prevalence of chronic disorders and viral infections among the masses, especially the geriatric population, which is more susceptible to thesemedical ailments, represents one of the major factors positively influencing the demand for anesthesia ETTs worldwide. In addition, the rising number of fatal road accidents and the growing number of trauma cases are driving the market. Apart from this, key players are introducing anesthesia ETTs with flexible tips that offer enhanced comfort and convenience to the users and assist in navigating through fragile airways with minimal discomfort. Furthermore, the escalating number of smokers and alcohol consumers is contributing to the market growth. Moreover, increasing incidences of airborne diseases on account of the rising air pollution arecreating a positive outlook in the market. Besides this, the expanding investments in improving healthcare infrastructure and medical services are projected to offer lucrative growth opportunities to industry investors.

KEY MARKET SEGMENTATION:

Breakup by Intubation Type:

• Nasotracheal
• Orotracheal
• Hybrid

Nasotracheal intubation dominates the market as it is easier to secure, moves less, minimizes the risk of trauma to lips, tongue, and larynx, and provides comfort to patients.

Breakup by Product Type:

• Regular Tubes
• Reinforced/Armored Tubes
• Coated Tubes
• Others

Coated tubes currently dominate the market.

Breakup by End User:

• Hospitals
• Ambulatory Surgery Centers
• Others

Anesthesia endotracheal tubes are extensively used in hospitals as it is an emergency procedure performed on people to maintain an open airway and help prevent suffocation.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America holds the majority of the global anesthesia endotracheal tubes market share due to the increasing prevalence of severe chronic ailments among the masses of the region.

COMPETITIVE LANDSCAPE:

The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Becton, Dickinson and Company, Convatec Limited, Fuji Systems Corp., General Electric (GE) Company, Intersurgical Ltd., Medtronic Private Limited, Neurovision Medical Products, SEWOON MEDICAL Co., Ltd., Smiths Group PLC, and Teleflex Incorporated.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global anesthesia endotracheal tubes market in 2025?

2. What is the expected growth rate of the global anesthesia endotracheal tubes market during 2026-2034?

3. What has been the impact of COVID-19 on the global anesthesia endotracheal tubes market?

4. What are the key factors driving the global anesthesia endotracheal tubes market?

5. What is the breakup of the global anesthesia endotracheal tubes market based on the intubation type?

6. What is the breakup of the global anesthesia endotracheal tubes market based on the product type?

7. What is the breakup of the global anesthesia endotracheal tubes market based on the end user?

8. What are the key regions in the global anesthesia endotracheal tubes market?

9. Who are the key players/companies in the global anesthesia endotracheal tubes market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Anesthesia Endotracheal Tubes Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Intubation Type

• 6.1 Nasotracheal
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Orotracheal
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Hybrid
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Product Type

• 7.1 Regular Tubes
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Reinforced/Armored Tubes
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Coated Tubes
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgery Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Becton, Dickinson and Company
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Convatec Limited
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
  • 14.3.3 Fuji Systems Corp
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 General Electric (GE) Company
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Intersurgical Ltd
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Medtronic Private Limited
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Neurovision Medical Products
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 SEWOON MEDICAL Co., Ltd
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
  • 14.3.9 Smiths Group PLC
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Teleflex Incorporated
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis